Pharmacogenetic (or PGx for short) testing is a type of genetic test that assesses a patient’s risk of an adverse response or likelihood to respond to a given drug, informing drug selection and dosing. As a pillar of the personalized medicine movement, PGx testing is anticipated to be important across all medical specialties, but particularly in primary care, where the majority of all drug prescriptions are written.
Like PGx, cancer-genetic testing (or CGx for short) is also a type of genetic test. However, rather than assess risks with prescribed drugs, CGx tests for and estimates a patients likelihood of developing cancer within their lifetime. This is done by looking at specific genes, chromosomes, and even proteins.
MBS is currently navigating these fields with great results and hope to offer billing services for these procedures soon!